BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2013205)

  • 1. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodiffusion method for detection of type A Clostridium botulinum.
    Ferreira JL; Hamdy MK; Zapatka FA; Hebert WO
    Appl Environ Microbiol; 1981 Dec; 42(6):1057-61. PubMed ID: 6797350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of type E botulinal toxin in cultures by fluorescent-antibody microscopy.
    Aalvik B; Sakaguchi G; Riemann H
    Appl Microbiol; 1973 Jan; 25(1):153-4. PubMed ID: 4568886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic growth and toxigenicity of Clostridium botulinum types A and B.
    Dezfulian M
    Folia Microbiol (Praha); 1999; 44(2):167-70. PubMed ID: 10588051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM; Modi NK; Roberts TA; Shone CC; Hambleton P; Melling J
    J Appl Bacteriol; 1987 Sep; 63(3):217-26. PubMed ID: 3323154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows.
    Krüger M; Skau M; Shehata AA; Schrödl W
    Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
    Keller JE
    Clin Vaccine Immunol; 2008 Sep; 15(9):1374-9. PubMed ID: 18667637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ganglioside affinity filters to identify toxigenic strains of Clostridium botulinum types C and D.
    Hayes S
    Infect Immun; 1979 Oct; 26(1):150-6. PubMed ID: 387601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
    Barash JR; Arnon SS
    J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
    Pittman PR; Hack D; Mangiafico J; Gibbs P; McKee KT; Friedlander AM; Sjogren MH
    Vaccine; 2002 May; 20(16):2107-15. PubMed ID: 11972980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay.
    Lewis GE; Kulinski SS; Reichard DW; Metzger JF
    Appl Environ Microbiol; 1981 Dec; 42(6):1018-22. PubMed ID: 7316509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
    Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
    J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.
    Siegel LS
    J Clin Microbiol; 1989 Aug; 27(8):1906-8. PubMed ID: 2768475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM; Modi NK; Roberts TA; Hambleton P; Melling J
    J Appl Bacteriol; 1988 Apr; 64(4):285-91. PubMed ID: 3049499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.